Riskpilot← Back to searchSign inGet full accessMEDPOINT AS
ASActiveOrg 828486462Slemdalsveien 1, 0369 OsloGeneral medical practice activities · NACE 8621Est. 20220 employees
Revenue 2024
NOK 3,8M
-41% vs 2023
EBITDA margin
18.2%
+71% vs 2023
Equity ratio
88.5%
Financial strength
Net profit 2024
NOK 539K
+72% vs 2023
| Revenue | NOK 3,8M | -41% |
| EBITDA | NOK 691K | +71% |
| Net profit | NOK 539K | +72% |
| Total assets | NOK 1,4M | +29% |
| Equity | NOK 1,2M | +81% |
| Employees | 0 | — |
Legal name
MEDPOINT AS
Org number
828486462
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
5. januar 2022
Share capital
NOK 99 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drift av legekontor og fastlegepraksis i tillegg til andre helsetjenester. Utleie av arbeidskraft og alt deromkring liggende. Eie og forvalte aksjer, andeler og andre former for deltakelse i andre virksomheter, annen konsulentvirksomhet i egen virksomhet og i andre selskap. Kjøp, salg og investering/utleie av eiendom, samt andre investeringer.
Address
Slemdalsveien 1, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 5 579 | 6 398 | 3 787 |
| Staff expenses | −0 | −0 | −5 |
| EBITDA | 329 | 404 | 691 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 329 | 404 | 691 |
| Net financials | 0 | −1 | −0 |
| Profit before tax | 329 | 403 | 691 |
| Tax | 73 | 90 | 152 |
| Net profit | 257 | 313 | 539 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 648 | 1 052 | 1 356 |
| Equity | 349 | 662 | 1 201 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 300 | 390 | 156 |
| Total debt | 300 | 390 | 156 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20222024
Equity ratio
88.5%
This company
38.2%
Market median
+132% vs market
20222024
Return on equity
44.9%
This company
18.4%
Market median
+144% vs market
20222024
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20222024
Asset turnover
2.79×
This company
1.12×
Market median
+149% vs market
20222024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HL Chief Executive Officer | Chief Executive Officer | 2022 |
HC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2023 | |
| Company | 33.33% | 33.33% | 2023 | |
| Company | 33.33% | 33.33% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Danzig As
MEDPOINT AS Board members of MEDPOINT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Lind | Chief Executive Officer | 0 companies |
| Henrik Christer Lind | Chief Executive Officer | 0 companies |
| Christer Torgilstveit Larsen | Chairman | 0 companies |
| Peder Anker | Board of Directors | 0 companies |